Skip to main content
HairCited

Zinco per Alopecia areata

F

Basato su 46 studi (3 meta-analyses, 1 RCT) con 23,495 partecipanti totali. I risultati sono contrastanti tra gli studi.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dzinc\u0026condition\u003Dalopecia\u002Dareata'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

F

In sintesi

While people with alopecia areata often have lower zinc levels, research is mixed on whether zinc supplementation helps — it may support overall immune health but is not a reliable solution for alopecia areata.

  • Lower zinc levels are consistently found in alopecia areata patients
  • Supplementation studies show inconsistent results for hair regrowth
  • Zinc plays a role in immune function, which is relevant to autoimmune hair loss
  • No large-scale RCT specifically tests zinc supplementation for alopecia areata

Key Study Findings

Review
Eyebrow Madarosis: An Updated Review of the Etiology and Management, Part I - Nonscarring Disorders.
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: review of nonscarring eyebrow alopecia etiologies and management (1960-2025)

Review
The role of trace elements for the function and health of the skin.
Dose: None vs: Placebo Effetto: None None
Meta-Analysis n=4931
Association Between Serum Trace Elements Level and Alopecia Areata: A Systematic Review and Meta-Analysis.
Dose: None vs: Placebo Effetto: SMD=-0.93 (vitamin D); SMD=-0.69 (zinc); OR=2.48 (vitamin D deficiency risk) p<0.05
Animal Study n=36
Associations between ionomic profile and metabolic abnormalities in a murine model of sodium sulfide induced …
Dose: Tofacitinib 1 mg/kg vs: Placebo Effetto: Differential metabolites and ions identified via OPLS-DA; Mg2+ correlated with CD8+ T cell modulatio None
Systematic Review and Meta-Analysis n=7014
Trace Elements and Risk of Immune-Mediated Skin Disease: A Systematic Review and Meta-analysis.
Dose: None vs: Placebo Effetto: Standardized mean differences reported for each element and disease combination (specific values not None

Key Statistics

60

Studi

23876

Partecipanti

Mixed

F

Grado

Referenced Papers

Acta dermato-venereologica 2023 11 citazioni
Skin appendage disorders 2020 10 citazioni
The Australasian journal … 2019 51 citazioni
Indian journal of … 2019 10 citazioni
American journal of … 2017 104 citazioni
Archives of biochemistry … 2016 124 citazioni
Clinics in dermatology 2016 19 citazioni
Acta dermatovenerologica Croatica … 2016 6 citazioni
Journal of the … 2016 4 citazioni
Annals of dermatology 2013 114 citazioni
Indian journal of … 2009 79 citazioni
Clinical and experimental … 2003 6 citazioni
Zeitschrift fur Hautkrankheiten 1987 3 citazioni
Giornale italiano di … 1986
Dermatologische Monatschrift 1984 3 citazioni
The British journal … 1981 58 citazioni
Zeitschrift fur Hautkrankheiten 1980
Przeglad dermatologiczny 1978 4 citazioni

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

general:
8-11 mg/day
hairloss:
15-30 mg/day

Limite massimo: 40 mg/day

Dosaggi studiati nella ricerca

Dosaggio Durata Effetto N
None -- Neutral --
None -- Mixed --
None -- Negative 4931
None -- Positive --
Tofacitinib 1 mg/kg -- Positive 36
None -- Mixed 7014
None -- Neutral 30
Corticosteroid injections (dose not specified) in transgenic mice -- Positive --

Momento migliore per l'assunzione: With meals to minimize stomach upset; separate from iron and calcium by 2 hours

Safety & Side Effects

Effetti collaterali segnalati

  • Nausea and vomiting (especially on an empty stomach)
  • Metallic taste in the mouth
  • Copper depletion with chronic high-dose use
  • Headache and diarrhea

Interazioni note

  • Copper supplements (zinc inhibits copper absorption at doses >40 mg/day)
  • Tetracycline and quinolone antibiotics (mutual absorption reduction)
  • Penicillamine (zinc reduces absorption of this rheumatoid arthritis drug)

Livello di assunzione massimo tollerabile: 40 mg/day

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Zinco help with Alopecia areata?
Based on 60 studies with 23,876 participants, there is insufficient evidence at this time that Zinco may support Alopecia areata management. Our evidence grade is F (Evidence Against).
How much Zinco should I take for Alopecia areata?
Studies have used various dosages. A commonly studied range is 8-11 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Zinco?
Reported side effects may include Nausea and vomiting (especially on an empty stomach), Metallic taste in the mouth, Copper depletion with chronic high-dose use, Headache and diarrhea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Zinco and Alopecia areata?
We rate the evidence as Grade F (Evidence Against). This rating is based on 60 peer-reviewed studies with 23,876 total participants. The overall direction of effect is mixed.

Related Evidence

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.